Jupiter Research Capital (Asia) Ltd’s MapLight Therapeutics MPLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,018
Closed -$287K – 1158
2026
Q2
$287K Buy
+8,018
New +$231K 0.03% 550

Other funds holding MPLT

Jupiter Research Capital (Asia) Ltd's MPLT Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of MapLight Therapeutics (MPLT) in Q3 2026, closing a stake of 8,018 shares — an estimated $287K sold.

Jupiter Research Capital (Asia) Ltd first reported a position in MPLT in Q2 2026 and held it in 1 quarter. The position peaked at $287K in Q2 2026. 85 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining MapLight Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 8,018 MapLight Therapeutics shares in Q3 2026, an estimated $287K.
  • Jupiter Research Capital (Asia) Ltd first reported a position in MapLight Therapeutics in Q2 2026 and held it in 1 quarter.
  • Jupiter Research Capital (Asia) Ltd's MapLight Therapeutics position peaked at $287K in Q2 2026.
  • 85 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.